BRD4 and neoplasm: Since UNI66 demonstrated no tumor growth inhibition, potentially attributable to solubility challenges in achieving effective treatment concentrations for zebrafish xenograft experiments (Supplementary Fig. S5A), we employed JQ1, a widely recognized BRD4 inhibitor, for an in vivo experiment aimed at tumor suppression.